Recent 2Q 2020 data from Pitchbook shows that venture capital funding into US-based biopharma companies was the largest quarter in the history of the industry – topping over $6.4B.  In the midst of the crazy macro backdrop, private biotechs raised more in the last three months than the annual totals in every year prior to 2014.

More on that at Life Sci VC